WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPDI) today announced it has appointed Christine Dingivan, M.D., as executive vice president and chief medical officer. She provides strategic direction for global regulatory affairs and pharmacovigilance, biomarker discovery sciences, Phase I, and bioanalytical and cGMP lab services. In addition, she holds primary responsibility for medical assessment of clinical data as well as adherence to ethical standards and good laboratory practices.
